0
0 (0%)
U.S. Stem Cell, Inc. [USRM]
Source:
Company Overview
U.s. Stem Cell, Inc. is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of disease and injury.
| Country | United States |
| Headquarters | sunrise, florida |
| Phone Number | 954-835-1500 |
| Industry | services |
| CEO | Mike Tomas |
| Website | us-stemcell.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0.1 |
| Operating Profit | $-1.7 |
| Net Income | $-2.9 |
| Net Cash | $-0 |
Profit Ratios
| Gross Margin | $0.1 |
| Operating Margin | -2,096.9 |
| Profit as % of Revenues | 71% |
| Profit as % of Assets | -4,801.7% |
| Profit as % of Stockholder Equity | 19.4% |
Management Effectiveness
| Return on Equity | 19.4% |
| Return on Assets | -4,200.4% |
| Turnover Ratio | 1.4% |
| EBITA |
Balance Sheet and Cash Flow Measures
| Total Assets | $0.1 |
| Total Liabilities | $14.8 |
| Operating Cash Flow | $-0.3 |
| Investing Cash Flow | |
| Financing Cash Flow | $0.3 |
